234 related articles for article (PubMed ID: 32800647)
1. A machine learning approach identified a diagnostic model for pancreatic cancer through using circulating microRNA signatures.
Alizadeh Savareh B; Asadzadeh Aghdaie H; Behmanesh A; Bashiri A; Sadeghi A; Zali M; Shams R
Pancreatology; 2020 Sep; 20(6):1195-1204. PubMed ID: 32800647
[TBL] [Abstract][Full Text] [Related]
2. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
[TBL] [Abstract][Full Text] [Related]
4. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
5. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling and bioinformatics analysis of circulating microRNAs in patients with acute myocardial infarction.
Zhong Z; Wu H; Zhong W; Zhang Q; Yu Z
J Clin Lab Anal; 2020 Mar; 34(3):e23099. PubMed ID: 31721304
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning Analysis of MicroRNA Expression Data Reveals Novel Diagnostic Biomarker for Ischemic Stroke.
Zhao X; Chen X; Wu X; Zhu L; Long J; Su L; Gu L
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105825. PubMed ID: 34022583
[TBL] [Abstract][Full Text] [Related]
8. Identification of Circulating Serum miRNAs as Novel Biomarkers in Pancreatic Cancer Using a Penalized Algorithm.
Lee J; Lee HS; Park SB; Kim C; Kim K; Jung DE; Song SY
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498271
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract][Full Text] [Related]
10. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.
Lin GB; Zhang CM; Chen XY; Wang JW; Chen S; Tang SY; Yu TQ
Math Biosci Eng; 2019 Nov; 17(1):834-844. PubMed ID: 31731380
[TBL] [Abstract][Full Text] [Related]
11. A Machine Learning Method for a Blood Diagnostic Model of Pancreatic Cancer Based on microRNA Signatures.
Huang B; Xin C; Yan H; Yu Z
Crit Rev Immunol; 2024; 44(3):13-23. PubMed ID: 38421702
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-125a-3p, -4530, and -92a as a Potential Circulating MicroRNA Panel for Noninvasive Pancreatic Cancer Diagnosis.
Seyed Salehi A; Parsa-Nikoo N; Roshan-Farzad F; Shams R; Fathi M; Asaszadeh Aghdaei H; Behmanesh A
Dis Markers; 2022; 2022():8040419. PubMed ID: 36254252
[TBL] [Abstract][Full Text] [Related]
13. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
[TBL] [Abstract][Full Text] [Related]
14. Combined use of Serum miR-499a-5p and CA199 Increases the Diagnostic Sensitivity of Pancreatic Cancer.
Shi Q; Feng K; Xia L; Wang C; Zhu J
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710444
[TBL] [Abstract][Full Text] [Related]
15. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
16. Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer.
Shi W; Wartmann T; Accuffi S; Al-Madhi S; Perrakis A; Kahlert C; Link A; Venerito M; Keitel-Anselmino V; Bruns C; Croner RS; Zhao Y; Kahlert UD
Br J Cancer; 2024 Jan; 130(1):125-134. PubMed ID: 37950093
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods.
Shams R; Saberi S; Zali M; Sadeghi A; Ghafouri-Fard S; Aghdaei HA
Sci Rep; 2020 May; 10(1):7559. PubMed ID: 32371926
[TBL] [Abstract][Full Text] [Related]
18. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.
Cao Z; Liu C; Xu J; You L; Wang C; Lou W; Sun B; Miao Y; Liu X; Wang X; Zhang T; Zhao Y
Oncotarget; 2016 Jul; 7(27):41575-41583. PubMed ID: 27223429
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
20. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
